NCT04119453 2024-06-24A Study to Evaluate the Efficacy and Safety of Rivoceranib in Participants With Recurrent or Metastatic Adenoid Cystic Carcinoma (ACC)Elevar TherapeuticsPhase 2 Terminated80 enrolled